During the past decade, JPAL North America conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "JPAL North America" #1 collaborator was "Harvard University" with 3 trials as a collaborator, "Massachusetts General Hospital" with 3 trials as a collaborator, "Stanford University" with 3 trials as a collaborator, "Yale University" with 3 trials as a collaborator and "Massachusetts Institute of Technology" with 2 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "JPAL North America" are "Covid19" (2 trials) and "Coronavirus" (1 trials). Many other conditions were trialed in "JPAL North America" in a lesser frequency.

Most popular intervention types in "JPAL North America" are "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "AMA Acknowledgement Drug Pricing" (1 trials), "Acknowledgement Racial Injustice AMA" (1 trials), "African American Sender Acknowledgement" (1 trials), "African American Sender in Informational Videos." (1 trials) and "Facebook Ads on the importance of staying safe during the Thanksgiving / Christmas holiday" (1 trials). Other intervention names were less common.

The vast majority of trials in "JPAL North America" are 3 trials for "All" genders.

Currently, there are NaN active trials in "JPAL North America". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in JPAL North America, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JPAL North America, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".